dorlimomab aritox

mAbexperimentalADC

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No
Payload
Ricin A chain

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dorlimomab aritox
  • mdx-ra
  • st-1 4197x-ra